Streetbeat News

Stock Prices

NYMT

New York Mortgage Trust (NASDAQ:NYMT) reported Q2 2024 GAAP EPS of $(0.29), missing the analyst estimate of $0.01 by a significant margin. The company also reported sales of $19.044 million, which fell short of the $23.479 million estimate but marked a 25.82% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:57 pm

PGRE

Paramount Group has adjusted its estimated FY24 Core FFO guidance from a range of $0.75 - $0.81 to $0.76 - $0.80, with an estimate of $0.77.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:57 pm

SRI

Stoneridge (NYSE:SRI) reported Q2 2024 adjusted EPS of $0.17, significantly beating the analyst estimate of $(0.02). However, sales of $237.059 million missed the $242.604 million estimate and were down 11.15% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:50 pm

ZETA

Zeta Global Holdings (NYSE:ZETA) reported Q2 2024 earnings of $0.13 per share, beating the analyst estimate of $0.10 by 30%. Sales were $227.839 million, surpassing the $212.446 million estimate by 7.25%. This represents a 160% increase in EPS and a 32.61% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:48 pm

CPSH

CPS Technologies (NASDAQ:CPSH) reported a significant decline in its Q2 financial performance, with a GAAP EPS of $(0.07), down from $0.04 YoY, and sales of $5.03M, down from $7.42M YoY.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:46 pm

AGI

Alamos Gold has announced that it remains well-positioned to achieve its full-year guidance and expects significant production growth at declining costs over the next several years.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:46 pm

EXAS

Exact Sciences Corp (NASDAQ:EXAS) shares surged after the company reported better-than-expected Q2 financial results. The company posted a quarterly loss of 9 cents per share, significantly beating the analyst consensus estimate of a 32-cent loss. Quarterly sales reached $699.264 million, surpassing the $690.003 million estimate and marking a 12.41% year-over-year increase. Screening revenue rose by 15% to $532 million, and Precision Oncology revenue increased by 6% to $168 million. The company also announced an exclusive licensing agreement with TwinStrand Biosciences. Exact Sciences maintained its full-year revenue guidance of $2.81 billion to $2.85 billion.

Portfolio Pulse from Erica Kollmann

July 31, 2024 | 9:45 pm

SUI

Sun Communities has reiterated its FY24 Core FFO per share guidance of $7.06 to $7.22, with an estimate of $7.12.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:44 pm

RGR

Sturm Ruger & Co (NYSE:RGR) reported Q2 2024 earnings of $0.47 per share, missing the analyst estimate of $0.76 by 38.16%. Sales were $130.761M, also below the $137.601M estimate, marking an 8.43% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:44 pm

META

SNAP

Snap Inc (NYSE:SNAP) shares are trading higher in after-hours trading, likely in sympathy with Meta Platforms Inc (NASDAQ:META), which reported better-than-expected earnings. Meta's strong advertising results and AI advancements are positively impacting Snap ahead of its own earnings report.

Portfolio Pulse from Adam Eckert

July 31, 2024 | 9:42 pm